Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The MRC Anatomical Neuropharmacology Unit at the University of Oxford (MRC ANU) closed on the 31 March after 30 years of world leading research on the complex networks of the brain. From 1 April, the ANU becomes  the Medical Research Council Brain Network Dynamics Unit at the University of Oxford (MRC BNDU). 

Our goal is to understand and exploit the interactions between nerve cells that are critical for brain functions, with a special focus on the brain circuits underlying movement and memory...we aim to develop and deliver novel therapies that specifically target the disturbed circuit interactions arising in disease.
- Professor Peter Brown

The new unit, led by director Professor Peter Brown, will build on the previous unit's success, using animal models and patients to understand brain circuitry in some of the most prevalent and debilitating brain disorders such as Parkinson’s disease, memory disorders and Alzheimer’s disease.

The MRC BNDU will be uniquely multidisciplinary and integrate research programmes covering clinical, experimental and computational neuroscience in both the Department of Pharmacology and the Nuffield Department of Clinical Neurosciences.

Read more...

Similar stories

John Jacob wins clinical academic research partnership for brain cancer project

The Medical Research Council awarded Dr John Jacob upwards of £200,000 to fund a project on brain cancer modelling.

New consortium to uncover mechanisms of neuropathic pain

Professor David Bennett is leading a new national research consortium to investigate neuropathic pain.

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.

Two neurologists awarded MRC Senior Clinical Fellowships

Two of our Associate Professors, Sarosh Irani and George Tofaris, have been awarded MRC Senior Clinical Fellowships.

Developing diagnostics for COVID-19

Associate Professor Sarosh Irani, who heads up our Autoimmune Neurology Group, has been funded by Mologic to help develop diagnostics for COVID-19.